<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363046">
  <stage>Registered</stage>
  <submitdate>2/05/2013</submitdate>
  <approvaldate>31/05/2013</approvaldate>
  <actrnumber>ACTRN12613000623796</actrnumber>
  <trial_identification>
    <studytitle>Mindfulness-Based Stress Reduction 'MBSR' impact on PolyCystic Ovary Syndrome 'PCOS' patients' stress levels.</studytitle>
    <scientifictitle>Mindfulness-Based Stress Reduction 'MBSR' impact in PolyCystic Ovary Syndrome 'PCOS' patients stress levels: a blind randomized controlled trial in females of reproductive age.</scientifictitle>
    <utrn>U1111-1134-8003</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>PolyCystic Ovary Syndrome (PCOS)</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Mindfulness-based stress reduction program, including mindfulness breathing training exercises. It is administered on enrollment day by the main investigator. The session lasts for 20 to 30 minutes, per patient. It is administered on individual basis. The investigator advises for the daily implementation of the program in daily routine, for about 15 to 20 minutes, once, daily. There is a scheduled meeting at the end of the week of 20 to 30 minutes, when the patients report on their progress and the frequency of their practice or the changes, they may observe in the past week.</interventions>
    <comparator>PCOS patients, who do not participate in the Mindfulness-Based Stress Reduction group. This is a two-armed, parallel group, randomized controlled study with a 1:1 allocation ratio of PCOS patients to treatment or non-treatment groups and at 8-weeks of follow-up.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Stress levels evaluation, measured by Daily Life, DASS-21, PCOS, PSS 14,  salivary cortisol levels and Placebo effect (See 'Credibility/Expectancy questionnaire' 36.	Devilly GJ, Borkovec TD. (2000). Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 31(2):73-86.) at baseline and at the end of the 8-weeks period.</outcome>
      <timepoint>8 weeks after initial evaluation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Descriptive epidemiology of the life routine of the PCOS patients, the factors, that affect the patients' life quality
and their possible association of the MBSR program to the placebo effect, using the questionnaires, mentioned above at the end of the 8 week period. </outcome>
      <timepoint>8 weeks after initial evaluation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with PCOS diagnosis, according to the Rotterdam Criteria.</inclusivecriteria>
    <inclusiveminage>11</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Pregnancy
2. Any genetic disorder or endocrine disease, which results in clinical or biochemical hyperandrogenemia.
3. Any kind of psychiatric disorder
4. Use of antipsychotic, antidepressant or anticolvusant medications
5. Current practice of any stress management technique or previous practice even in two months before the enrollment.
6. Refusal to participate or comply with the 8 weeks MBSR program
7. Participation in other studies.
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation is not concealed.</concealment>
    <sequence>Simple randomization using  a randomization table, created by an online computer software. (www.random.org)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>N/A</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2012</anticipatedstartdate>
    <actualstartdate>11/09/2012</actualstartdate>
    <anticipatedenddate>30/03/2013</anticipatedenddate>
    <actualenddate>30/03/2013</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Greece</country>
      <state>Athens</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Charikleia Stefanaki, M.D., M.Sc. Candidate</primarysponsorname>
    <primarysponsoraddress>34 Vyzantiou Str. Athens Postcode:12242</primarysponsoraddress>
    <primarysponsorcountry>Greece</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>National &amp; Kapodistrian University  Medical School, Athens.</fundingname>
      <fundingaddress>Postgraduate M.Sc. Course ''Stress Management and Health Promotion''- Biomedical Research Foundation - Academy of Athens - 4 Soranou Ephessiou Str - Postcode: 115 27 Athens</fundingaddress>
      <fundingcountry>Greece</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to measure the MBSR program efficacy in decreasing stress levels in the PCOS patients. If the MBSR program proves to be efficient in decreasing stress levels, then it should integrated in the current management, along with the treatment.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Evgenideion Hospital, Athens, Greece</ethicname>
      <ethicaddress>20 Papadiamantopoulou Str.  Athens, Greece Postcode : 11528</ethicaddress>
      <ethicapprovaldate>30/08/2012</ethicapprovaldate>
      <hrec>n/a</hrec>
      <ethicsubmitdate>28/08/2012</ethicsubmitdate>
      <ethiccountry>Greece</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Charikleia Stefanaki</name>
      <address>Dr. Charikleia Stefanaki, 34, Vyzantiou Str. Athens, Greece, Postcode: 12242</address>
      <phone>+306937036030</phone>
      <fax />
      <email>cstefanak@med.uoa.gr</email>
      <country>Greece</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Charikleia Stefanaki</name>
      <address>Dr. Charikleia Stefanaki, 18 Alkmanos Str., Athens, Greece, Postcode: 11528</address>
      <phone>+306937036030</phone>
      <fax />
      <email>cstefanak@med.uoa.gr</email>
      <country>Greece</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Charikleia Stefanaki</name>
      <address>34, Vyzantiou Str. Athens, Greece, P.O.Box: 12242</address>
      <phone>+306937036030</phone>
      <fax />
      <email>cstefanak@med.uoa.gr</email>
      <country>Greece</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Charikleia Stefanaki</name>
      <address>Dr. Charikleia Stefanaki, 34, Vyzantiou Str. Athens, Greece, Postcode: 12242</address>
      <phone>+306937036030</phone>
      <fax />
      <email>cstefanak@med.uoa.gr</email>
      <country>Greece</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>